These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 6144351

  • 1. Reversal with balsalazide of infertility caused by sulphsalazine.
    McIntyre PB, Lennard-Jones JE.
    Br Med J (Clin Res Ed); 1984 Jun 02; 288(6431):1652-3. PubMed ID: 6144351
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Sulphasalazine-induced reversible male infertility.
    Delaere KP, Strijbos WE, Meuleman EJ.
    Acta Urol Belg; 1989 Jun 02; 57(1):29-33. PubMed ID: 2566274
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Balsalazide.
    Prakash A, Spencer CM.
    Drugs; 1998 Jul 02; 56(1):83-9; discussion 90. PubMed ID: 9664201
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A double-blind comparison of balsalazide, 6.75 g daily, and sulfasalazine, 3 g daily, in patients with newly diagnosed or relapsed active ulcerative colitis.
    Green JR, Mansfield JC, Gibson JA, Kerr GD, Thornton PC.
    Aliment Pharmacol Ther; 2002 Jan 02; 16(1):61-8. PubMed ID: 11856079
    [Abstract] [Full Text] [Related]

  • 9. Review article: balsalazide therapy in ulcerative colitis.
    Ragunath K, Williams JG.
    Aliment Pharmacol Ther; 2001 Oct 02; 15(10):1549-54. PubMed ID: 11563993
    [Abstract] [Full Text] [Related]

  • 10. Balsalazide: a review of its therapeutic use in mild-to-moderate ulcerative colitis.
    Muijsers RB, Goa KL.
    Drugs; 2002 Oct 02; 62(11):1689-705. PubMed ID: 12109930
    [Abstract] [Full Text] [Related]

  • 11. Sulfasalazine-induced abnormal sperm penetration assay reversed on changing to 5-aminosalicylic acid enemas.
    Chatzinoff M, Guarino JM, Corson SL, Batzer FR, Friedman LS.
    Dig Dis Sci; 1988 Jan 02; 33(1):108-10. PubMed ID: 2892654
    [Abstract] [Full Text] [Related]

  • 12. The short- and long-term safety of 5-aminosalicylate products in the treatment of ulcerative colitis.
    Baker DE, Kane S.
    Rev Gastroenterol Disord; 2004 Jan 02; 4(2):86-91. PubMed ID: 15185719
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Male infertility related to 5-ASA enemas.
    Friedman LS.
    Dig Dis Sci; 1989 May 02; 34(5):803. PubMed ID: 2565799
    [No Abstract] [Full Text] [Related]

  • 15. Balsalazide led to greater remission rates and tolerance than mesalamine in acute ulcerative colitis.
    Hanauer SB.
    Gut; 1999 Apr 02; 44(4):455. PubMed ID: 10075949
    [No Abstract] [Full Text] [Related]

  • 16. A randomized, double blind, dose-response comparison of balsalazide (6.75 g), balsalazide (2.25 g), and mesalamine (2.4 g) in the treatment of active, mild-to-moderate ulcerative colitis.
    Levine DS, Riff DS, Pruitt R, Wruble L, Koval G, Sales D, Bell JK, Johnson LK.
    Am J Gastroenterol; 2002 Jun 02; 97(6):1398-407. PubMed ID: 12094857
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Balsalazide disodium.
    Am J Health Syst Pharm; 2002 Jan 01; 59(1):27. PubMed ID: 11813462
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pentasa in lieu of sulfasalazine.
    Mulder CJ, Tytgat GN, Dekker W, Terpstra IJ.
    Ann Intern Med; 1988 Jun 01; 108(6):911-2. PubMed ID: 2897181
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.